Perry et al.

Aim

To investigate whether oxytocin affects preferred interpersonal distance differently in people with high and low levels of empathy.

Sample

• 54 male undergraduate volunteers from the University of Haifa in Israel.

• Participants were aged 19–32.

• They completed an empathy questionnaire and were classified into high- and low-empathy groups for the main analyses.

Procedure

• Participants took part in two sessions, one week apart.

• In one session they received oxytocin; in the other they received a saline placebo.

• The study used a double-blind procedure, meaning participants and the experimenter were unaware of which solution was administered at the time.

• Participants completed a computerized task in which figures representing a friend, stranger, authority figure or a non-social object approached them. They indicated when the figure was too close.

• In a second task, participants made choices about the arrangement of chairs and other objects in a room.

• Researchers compared preferred distances under oxytocin and placebo conditions.

Results

• Preferred distance varied depending on who or what was approaching.

• Participants generally preferred less distance from a friend than from a stranger.

• The effect of oxytocin depended on empathy level: the overall pattern suggested closer interpersonal distances among highly empathic men and greater distance among less empathic men.

• Some of the statistical evidence for the interaction was weak, so the findings should not be treated as definitive proof.

Conclusion

Oxytocin does not necessarily make everyone more sociable or comfortable with closeness. Its relationship with personal space may depend on individual differences such as empathy and on the social context.

Strengths

• Double-blind, placebo-controlled design: Helps reduce participant expectations and experimenter bias.

• Repeated measures: Each participant experienced both conditions, reducing the effect of stable individual differences.

• Standardized tasks: Computerized measures make distances easier to compare consistently.

• Non-social comparison: The study also examined responses involving objects, helping distinguish social from non-social spacing.

Weaknesses

• Male-only sample: Results cannot automatically be generalized to women.

• Limited cultural representation: Participants came from one university in Israel.

• Artificial tasks: Computer animations and furniture arrangements may not reflect all real-life social encounters.

• Statistical uncertainty: Some of the reported interaction evidence was not conventionally statistically significant.

• Empathy groups: Categorizing a continuous characteristic into high and low groups can lose useful information.

Research method

• Two experiments comparing oxytocin with a placebo, alongside questionnaires.

Variables

• IV: oxytocin versus placebo.

• DVs: measures of preferred interpersonal distance. Empathy was a measured individual-difference variable.

Data collection - quantitive and qualitative

• Computerized distance ratings, picture choices and questionnaire scores.

• Mainly quantitative distance measures and questionnaire scores; picture choices can also be treated as categorical data.

Mean and standard deviation

• Compare mean distance ratings for oxytocin and placebo groups

• Use SD to show individual variation. A bar chart can compare conditions; a scatter graph can examine the association between empathy scores and distance preferences.

Correlation vs Causation

• If treatment was randomly allocated and other conditions controlled, differences between oxytocin and placebo can support a causal conclusion. A correlation between empathy and personal space does not establish causation.

Validity

• A placebo comparison helps control expectations, but selecting a room or rating a scale may not represent actual interpersonal behavior.

Reliability

• Standardized scales and procedures support consistency; questionnaire accuracy and individual interpretation can affect results.

Generalizability

• Findings may depend on the sample, dosage, task and social context.

Ethics

• Informed consent, medical screening where appropriate, confidentiality and protection from potential side effects.

Experimental Design

• Treatment and placebo comparisons; the exact allocation and matching details should be learned from your class notes.

Evaluation

• A placebo condition and multiple measurement techniques are strengths; artificial measures of personal space limit ecological validity.